Health & Veritas

Howard Forman and Harlan Krumholz, two Yale physician-professors, discuss the latest news and ideas in healthcare and seek out the truth amid the noise.

Produced with the Yale School of Management and the Yale School of Public Health. New episodes are available every Thursday.

Latest episode
Health & Veritas show art

Howard P. Forman

Professor of Radiology and Biomedical Imaging, Economics, Public Health, and Management; Co-founder, Pozen-Commonwealth Fund Fellowship in Health Equity Leadership, MD/MBA Program, and MBA for Executives Program
Photo of Howard Forman
Bio

Professor Forman is a Professor of Diagnostic Radiology (and faculty director for Finance), Public Health (Health Policy), Economics and Management. Professor Forman directs the Health Care management program in the Yale School of Public Health and teaches healthcare economics in the Yale College Economics Department. He is the faculty founder and director of the MD/MBA program as well as the faculty director of the healthcare focus area in the School of Management’s MBA for Executives program. He is the co-founder and special advisor to the Pozen-Commonwealth Fund Fellowship in Health Equity Leadership program. He co-hosts the Health & Veritas podcast with Dr. Harlan Krumholz.

As a practicing emergency/trauma radiologist, he is actively involved in patient care and issues related to financial administration, healthcare compliance, and contracting. His research has been focused on improving imaging services delivery through better access to information. He has worked as a health policy fellow in the U.S. Senate, on Medicare legislation.

During the COVID Pandemic, Professor Forman has actively tracked outbreaks at local, national, and international levels; expounding on mitigation strategies and engaging to dispel misinformation through social and print media. He has been a frequent guest commentator and expert on national video and audio platforms.

Harlan M. Krumholz

Harold H. Hines, Jr. Professor of Medicine and Professor in the Institute of Social Policy Studies, of Investigative Medicine, and of Public Health (Health Policy); and Director of the Yale Center for Outcomes Research and Evaluation
Harlan Krumholz
Bio

Harlan Krumholz is a cardiologist and scientist at Yale University and Yale New Haven Hospital. He is the Harold H. Hines, Jr. Professor of Medicine, and Professor in the Institute of Social Policy Studies, of Investigative Medicine, and of Public Health (Health Policy), and the Director of the Yale Center for Outcomes Research and Evaluation. He is a leading expert in the science to improve the quality and efficiency of care, eliminate disparities and promote equity, improve integrity and transparency in medical research, engage patients in their care, and avoid wasteful practices. Recent efforts are focused on harnessing the digital transformation in healthcare to accelerate knowledge generation and facilitate the delivery of care aligned with each patient’s needs and preferences.

Dr. Krumholz is director of the Yale New Haven Hospital Center for Outcomes Research and Evaluation (CORE), an organization dedicated to improving health and health care through research, tools, and practices that produce discovery, heighten accountability and promote better public health and clinical care. He co-founded and co-leads the Yale University Open Data Access (YODA) Project, designed to increase access to clinical research data and promote their use to generate new knowledge. He also co-founded and co-leads medRxiv, a non-profit preprint server for the medical and health sciences. He was a founding faculty co-director of the Yale Center for Research Computing.

Dr. Krumholz has been honored by membership in the National Academy of Medicine, the Association of American Physicians, and the American Society for Clinical Investigation. He was named a Distinguished Scientist of the American Heart Association and received their Award of Meritorious Achievement and their Clinical Research Prize. He served as a member of the Advisory Committee to the Director of the National Institutes of Health. Dr. Krumholz received the Friendship Award from the People’s Republic of China in recognition of his collaborative efforts to develop a national cardiovascular research network and was named by the Chinese Society of Cardiology as a Top-10 Distinguished International Cardiologist for his contributions to the development of cardiovascular medicine in China. He founded the American Heart Association’s Quality of Care and Outcomes Research Council and co-founded their annual conference. He was the founding editor of Circulation: Cardiovascular Quality and Outcomes; founding editor of CardioExchange, a social media site of the publisher of the New England Journal of Medicine; and editor of Journal Watch Cardiology of the New England Journal of Medicine. He was a founding Governor of the Patient-Centered Outcomes Research Institute.

Episodes

  • Podcast
    Episode 120
    Duration 31:45

    Robert Rohrbaugh: Bringing Antiracist Tools to Clinical Practice

    Howie and Harlan are joined by Robert Rohrbaugh, professor of psychiatry and deputy dean for professionalism and leadership at the Yale School of Medicine, to discuss his work training doctors in antiracist practices and ensuring the wellbeing of clinicians during the pandemic. Harlan reports on the problematic history of medical journals promoting eugenics; Howie highlights a cyberattack that has paralyzed Change Healthcare, the country’s largest payments processing hub.

  • Podcast
    Episode 119
    Duration 42:18

    A Cheating Scandal, Abandoned Research, and Other News

    Howie and Harlan discuss health and healthcare headlines, including a cheating scandal that has led to the invalidation of hundreds of scores from Nepal on the U.S. Medical Licensing Examination, the problem of research that never sees the light of day, new anti-obesity medications, and Florida’s unorthodox approach to measles.
  • Podcast
    Episode 118
    Duration 30:35

    Lucila Ohno-Machado: AI and the Art of Medicine

    Howie and Harlan are joined by Lucila Ohno-Machado, the Yale School of Medicine’s deputy dean for biomedical informatics. She explains how expanding use of data science, informatics, AI, and technology could enable doctors to spend more time with patients. Harlan celebrates mentorship while marking the death of Irwin Birnbaum, a mentor to many in his time as COO of the Yale Medical School and long after retiring. Howie discusses the mixed evidence from a study on vaping as a tool for helping cigarette smokers quit.
  • Podcast
    Episode 117
    Duration 38:22

    Farzad Mostashari: Aligning Incentives to Fix Primary Care

    Howie and Harlan are joined by Farzad Mostashari, co-founder and CEO of Aledade, an "accountable care organization" that seeks to align patient-provider incentives so doctors can make a profit by prioritizing preventive care. Harlan discusses a study suggesting that physical exercise may be protective from severe COVID. Howie highlights the introduction of Apple’s VR headset and the importance of further study to understand the technology’s capacity to “rewire” our brains.
  • Podcast
    Episode 116
    Duration 30:38

    Christopher O’Connor: Hospital Leadership in Trying Times

    Howie and Harlan are joined by Christopher O’Connor, CEO of Yale New Haven Health, to discuss his career path and his experience leading hospitals through Hurricane Katrina and COVID-19. Harlan reports on promising AI tools for taking clinical notes; Howie looks at the financial headwinds facing the companies offering Medicare Advantage plans.

  • Podcast
    Episode 115
    Duration 30:14

    Manisha Juthani: Solving Infectious Disease Mysteries

    Howie and Harlan are joined by Manisha Juthani, a Yale infectious disease specialist and commissioner of the Connecticut Department of Public Health. They discuss her research, including a study casting doubt on the use of cranberries to prevent urinary tract infection, and her priorities for Connecticut. Harlan reports on a wave of study retractions from the Dana-Farber Cancer Institute; Howie reflects on the progress made toward eradicating Guinea worm and malaria.

  • Podcast
    Episode 114
    Duration 33:04

    Claudine Litman: Designing Better Healthcare Solutions

    Howie and Harlan are joined by Yale SOM alum Claudine Litman, a designer and the director of Yale‘s Center for Outcomes Research & Evaluation, to talk about using the tools of design to build more effective healthcare spaces and processes. Harlan looks at seven charts illustrating the state of healthcare in 2023; Howie reports on the FDA reprimanding a drug company for misleading advertising.
  • Podcast
    Episode 113
    Duration 35:14

    Reshma Ramachandran: Will the Supreme Court Upend Healthcare Regulation?

    Howie and Harlan are joined by Reshma Ramachandran, a Yale family physician and co-director of Yale Collaboration for Regulatory Rigor, Integrity, and Transparency. They discuss the potential ramifications for healthcare regulation if the Supreme Court overturns the Chevron decision requiring judges to defer to federal agencies. Harlan looks at surveys suggesting an erosion of trust in medicine; Howie reports on the growing measles outbreak.
  • Podcast
    Episode 112
    Duration 31:33

    Another Winter Wave, and Other News

    Howie and Harlan discuss the winter wave of COVID-19 and Howie’s experience with the Novovax vaccine, report on potential side effects of the next-generation weight-loss drugs, and unpack the economics of Florida’s plan to import drugs from Canada.

  • Podcast
    Episode 111
    Duration 35:33

    Julie Ann Sosa: Personalizing Treatment of Thyroid Cancer

    Howie and Harlan are joined by Julie Ann Sosa, chair of the University of California San Francisco department of surgery. She reports on new approaches to treating thyroid nodules, addressing sexual harassment within the medical profession, and supporting personal and professional success for doctors caring for elderly parents. Harlan and Howie discuss the upswing in COVID-19 cases and research on whether the benefits of exercise could be delivered by a pill.